Survey urges need for French medtech assessment
This article was originally published in Clinica
France needs to invest Fr7,000 million ($980 million) in high-tech imaging equipment to ensure that it keeps progress with scientific and medical progress. That is the conclusion of a study by French medical data research group, Sanesco. It estimates that 300 additional MRI systems are needed to bring France up to a level of eight per million inhabitants, which would nevertheless still be lower than the German ratio. Sanesco recognises that the level of investment is a huge sum for the government to find, but adds that there would be direct savings in terms of earlier diagnosis, shorter waiting times and shorter hospital stays.
You may also be interested in...
Liquid biopsy start-up Grail Inc. announced that a study of almost 6,700 participants found that its blood test could detect more than 50 types of cancer with a low false-positive rate. See what Minetta Liu, study co-lead author and a Mayo Clinic professor of oncology, had to say about the research.
Sanofi’s next-generation meningococcal vaccine, broader use of Bristol-Myers Squibb’s Reblozyl move toward approval; United Therapeutics foreshadows Trevyent regulatory difficulties.
Biopharma is working on a reputation renaissance as the public looks to industry for treatments and vaccines for the COVID-19 epidemic and drug pricing concerns take a back seat.